Patent · US Active

Blood cell biomarker for late onset Alzheimer's disease

US11567078B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 31, 2016
Grant dateJan 31, 2023
Priority date
Expiry dateOct 17, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are compositions and methods for diagnosing late-onset Alzheimer's disease (LOAD), treating LOAD and assessing efficacy of therapeutic agents used to treat LOAD.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.